Lilly Pulitzer is serving up a Valentine's Day partnership with Lele Sadoughi, the New York-based accessories brand. Marking their second collaboration, "Lilly Loves Lele" is a six-piece limited ...

President Donald Trump scored a significant legal win Monday in his lawsuit against the members of the Pulitzer Prize Board, paving the way towards the discovery phase in their courtroom battle.

Investors should watch key support levels on Eli Lilly's chart around $720 and $625, while also monitoring important overhead areas near $860 and $965. Eli Lilly (LLY) shares could remain under ...

The company has successfully secured over 20 projects worldwide, totaling $400M to customers including Oxford Industries (Tommy Bahama, Lilly Pulitzer, Southern Tide, etc.), Grainger, and E ...

Eli Lilly & Co.’s fourth-quarter revenue fell short of analysts’ estimates as the drugmaker struggled to forecast demand for its popular weight-loss and diabetes shots for the second quarter ...

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Bell’s career as a cartoonist spans decades, earning him significant accolades, including the 2019 Pulitzer Prize for editorial cartoons. His award-winning work, praised for tackling issues such ...

Whether you’re after specific iPhone dimensions or want an iPhone screen size comparison chart to help visualize your options, we’ve got you covered. Let’s compare iPhone sizes to help you find the ...

Eli Lilly recently updated Q4 revenue guidance, and sales are expected to come in lower than previously anticipated. While this could suggest the company is experiencing sluggish or plateauing ...

What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...

Eli Lilly's stock price finished Jan. 16 down 21% from a peak it set last September. The sales trajectory of Mounjaro and Zepbound tapered off in the second half of 2024. An oral weight-loss ...

In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic response at one year Among those who achieved clinical ...